Business
CSL and research partners give up on plans to develop COVID treatment – Sydney Morning Herald
Australia’s local vaccine producer and its partners have been forced to shelve research on a possible COVID treatment after its phase 3 trial failed to convince…
While the results of this particular clinical trial are disappointing, we are proud that as an industry we proactively and collaboratively pursued this work, and that the program may contribute to a growing understanding of this challenging virus and strategies for patient care, said Bill Mezzanotte, executive vice president and head of research and development and chief medical officer at CSL Behring.
Since we embarked on this development program, and throughout the pandemic, we have learned much…
-
Business24 hours agoHow to retire in your 50s with ASX shares
-
General24 hours agoFood and garden organic waste bin system on verge of collapse across WA’s South West
-
Noosa News22 hours agoBig Brother’s Mike Goldman reveals what saved his life after waking up to find Brisbane home engulfed in fire
-
Business22 hours agoWhy is the Super Retail share price tumbling today?